A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group, Phase 1 Study to Compare the Tolerability of OROS Paliperidone (Extended Release) With Immediate-Release (IR) Risperidone in Subjects With Schizophrenia.
Phase of Trial: Phase I
Latest Information Update: 31 Mar 2010
At a glance
- Drugs Paliperidone; Risperidone
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Janssen Research & Development
- 28 Nov 2008 New trial record.